Research Briefs

Probiotic Strain Cuts Salmonella in Broilers, Poultry Science Study Finds

A Poultry Science study (Vol. 105, Issue 12, Dec. 2026) reports that dietary Weizmannia faecalis DSM 32016 reduced Salmonella colonization and supported growth in challenged broilers.

Updated

A probiotic strain reduced Salmonella colonization and supported growth performance in broilers experimentally challenged with Salmonella enterica serovars, according to a study published in Poultry Science, Volume 105, Issue 12, dated December 2026.

The paper, authored by Lydia Zeibich, Alexandra Schlagheck, Ali R. Al Sulaiman, Max Ingberman, Ala E. Abudabos and Breno Castello Branco Beirão, examines dietary supplementation with Weizmannia faecalis DSM 32016 in birds facing Salmonella challenge — a combination the authors frame as relevant to both bird performance and the broader pressure of foodborne pathogen control in poultry production.

What did the researchers test?

The study centers on a single, precisely identified probiotic strain: Weizmannia faecalis DSM 32016, delivered through the diet. The challenge organism was not a single agent but multiple Salmonella enterica serovars, which matters at the practice level. Broiler flocks in the field rarely face one serovar at a time, and an intervention evaluated against several serovars carries more weight than one tested against a single laboratory strain.

The two outcome categories the title names are distinct and separately relevant. Reduced Salmonella colonization speaks to pathogen load in the bird — the variable that drives food-safety risk downstream in the processing chain. Supported growth performance speaks to the producer's ledger: weight gain and feed efficiency under pathogen challenge, the numbers that determine whether a flock turns a profit.

Where does this fit in food-animal practice?

For poultry veterinarians and production managers, Salmonella control in broilers currently rests on a layered toolkit: biosecurity, coccidiosis management, feed additives and, in some markets, vaccines. Probiotics occupy a contested space within that toolkit. A peer-reviewed demonstration that a named strain reduces colonization across multiple Salmonella enterica serovars gives practitioners a specific organism — Weizmannia faecalis DSM 32016, with a DSMZ deposit number that can be traced — rather than the generic "probiotic" label that has long complicated product comparisons.

The publication venue matters as well. Poultry Science is the flagship journal of the Poultry Science Association, and studies appearing there undergo the peer review that regulatory bodies and feed-additive formulators typically look to when weighing claims.

What are the companion-animal and public-health implications?

The study addresses broilers, and its findings transfer directly only to poultry. But the public-health dimension of Salmonella in broiler flocks extends well beyond the barn. Salmonella enterica remains a leading cause of foodborne illness traced to poultry products, and interventions that reduce colonization in live birds act earlier in the chain than any measure applied at processing or in the kitchen.

Whether Weizmannia faecalis DSM 32016 moves from peer-reviewed evidence to labeled commercial use will depend on regulatory review — in the United States, feed-additive claims of this type fall under FDA oversight, and in the European Union under EFSA evaluation. The study itself, as indexed, reports the research findings without indication of a pending regulatory submission.

What remains to be seen?

The title reports both outcomes — reduced colonization and supported growth — as findings of the supplementation regimen under challenge conditions. Readers seeking the specific dosing regimen, duration of feeding, magnitude of colonization reduction and growth-performance figures will find them in the full text of the December 2026 issue of Poultry Science, Volume 105, Issue 12.

What the study establishes at minimum is that this strain, under experimental Salmonella enterica challenge in broilers, produced measurable benefits on both the pathogen and performance axes. Field validation across commercial conditions, dose optimization and cost-effectiveness calculation are the predictable next questions for practitioners considering the finding. As the December 2026 publication date indicates, the work is fresh, and its absorption into production protocols will depend on how those follow-up questions are answered.

Source: Poultry Science (Elsevier)

Share this article:

Nathan Brooks

Show full bio

Senior reporter covering companies, deals and strategy in Small- and large-animal clinical practice at The Vet Scope.

More from Nathan Brooks →